WRAP trial publications on the MRC Epidemiology Unit publications database.
Selected publications
Ahern AL, Breeze P, Fusco F, et al. (2022) Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial. Lancet Public Health. 7(10): e866-e875.
Bates S, Norman P, Breeze P, et al. (2022) Mechanisms of Action in a Behavioral Weight-Management Program: Latent Growth Curve Analysis. Annals of Behavioral Medicine. 56(1):64-77.
Jones RA, Mueller J, Sharp SJ, et al. (2022) Long-term impact of a behavioral weight management program on depression and anxiety symptoms: 5-year follow-up of the WRAP trial. Obesity. 30(12): 2396- 2403.
Jones RA, Mueller J, Sharp SJ, et al. (2022) Participant Characteristics Associated with Changes in Mental Health in a Trial of Behavioural Weight Management Programmes: Secondary Analysis of the WRAP Trial. Obesity Facts. 15(4):508-518
Jones RA, Mueller J, Sharp SJ, et al. (2021). The impact of participant mental health on attendance and engagement in a trial of behavioural weight management programmes: secondary analysis of the WRAP randomised controlled trial. International Journal of Behavioral Nutrition and Physical Activity. 18(1)
Breeze P, Gray LA, Thomas C, et al. (2022) Estimating the impact of changes in weight and BMI on EQ-5D-3L: a longitudinal analysis of a behavioural group-based weight loss intervention. Quality of Life Research. 31(11):3283-3292.
Heath L, Jebb S, Stevens R, et al. (2022) Effects of a group-based weight management programme on anxiety and depression: A randomised controlled trial. PLOS ONE 17(2): e0263228.
Mead BR, Boyland EJ, Christiansen P, et al. (2021) Associations between hedonic hunger and BMI during a two-year behavioural weight loss trial. PLOS ONE 16(6): e0252110.
Morris E, Jebb SA, Oke J et al. (2021) Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes. British Journal of General Practice. 71(705): e312-e319.
Piernas C, MacLean F, Aveyard P, et al. (2020) Greater Attendance at a Community Weight Loss Programme over the First 12 Weeks Predicts Weight Loss at 2 Years. Obesity Facts. 13:349-360.
Ahern AL, Griffin SJ, Wheeler GM, et al. (2020) The effect of referral to an open-group behavioural weight-management programme on the relative risk of normoglycaemia, non-diabetic hyperglycaemia and type 2 diabetes: Secondary analysis of the WRAP trial. Diabetes Obesity and Metabolism. 22: 2069– 2076.
Lawlor ER, Hughes CA, Duschinsky R, et al. (2020) Cognitive and behavioural strategies employed to overcome “lapses” and prevent “relapse” among weight-loss maintainers and regainers: A qualitative study. Clinical Obesity. 10:e12395.
Ahern AL, Wheeler GM, Aveyard PN, et al. (2017) Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Lancet. 389(10085); 2214-2225
Ahern AL, Aveyard P, Boyland EJ, et al. (2016) Inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care. British Journal of General Practice. 66(645): e258-e263
Allen JT, Cohn SR, Ahern AL. (2016) Experiences of a commercial weight-loss programme after primary care referral: a qualitative study. British Journal of General Practice. 65(633): e248-e255
Ahern AL, Aveyard PN, Halford JCG, et al. (2014) Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral for 52 weeks and a brief self-help intervention BMC Public Health. 14(620)
